ROR1
receptor tyrosine kinase like orphan receptor 1, the group of I-set domain containing|Receptor tyrosine kinases
Basic information
Region (hg38): 1:63774016-64181498
Previous symbols: [ "NTRKR1" ]
Links
Phenotypes
GenCC
Source:
- hearing loss, autosomal recessive 108 (Moderate), mode of inheritance: AR
- hearing loss, autosomal recessive 108 (Limited), mode of inheritance: AR
- hearing loss, autosomal recessive (Supportive), mode of inheritance: AR
- nonsyndromic genetic hearing loss (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Deafness, autosomal recessive 108 | AR | Audiologic/Otolaryngologic | Early recognition and treatment of hearing impairment may possibly benefit developmental outcomes in some individuals, including speech and language development | Audiologic/Otolaryngologic | 27162350 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (90 variants)
- Inborn genetic diseases (21 variants)
- Hearing loss, autosomal recessive 108 (7 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ROR1 gene is commonly pathogenic or not.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 18 | 10 | 28 | |||
missense | 1 | 60 | 3 | 1 | 65 | |
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice variant | 1 | 1 | 2 | |||
non coding | 2 | 10 | 12 | |||
Total | 1 | 0 | 60 | 24 | 22 |
Variants in ROR1
This is a list of pathogenic ClinVar variants found in the ROR1 region.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-63774394-G-A | Benign (May 22, 2021) | |||
1-63774431-G-T | Inborn genetic diseases | Uncertain significance (Nov 08, 2022) | ||
1-63774440-G-A | Uncertain significance (Oct 05, 2022) | |||
1-63774451-C-T | Uncertain significance (Sep 07, 2022) | |||
1-63774459-G-GGCGCTGCTGGCC | Uncertain significance (Oct 13, 2021) | |||
1-63774491-G-A | Inborn genetic diseases | Uncertain significance (Oct 26, 2021) | ||
1-63774516-G-T | Likely benign (Oct 19, 2022) | |||
1-63774569-C-T | Benign (May 14, 2021) | |||
1-64009132-C-T | Benign (May 14, 2021) | |||
1-64009249-A-G | Benign (May 24, 2021) | |||
1-64009337-C-T | Inborn genetic diseases | Uncertain significance (May 23, 2023) | ||
1-64009338-C-G | Uncertain significance (Aug 27, 2021) | |||
1-64009338-C-T | Inborn genetic diseases | Uncertain significance (Oct 26, 2022) | ||
1-64009387-G-T | Benign (Oct 23, 2022) | |||
1-64049683-G-T | Benign (Oct 25, 2022) | |||
1-64049707-C-T | Hearing loss, autosomal recessive 108 | Benign (Nov 01, 2022) | ||
1-64049734-G-A | Benign/Likely benign (Jan 01, 2023) | |||
1-64049895-C-T | Uncertain significance (Aug 14, 2021) | |||
1-64050507-A-AT | Benign (May 20, 2021) | |||
1-64050702-A-G | Likely benign (Nov 01, 2021) | |||
1-64050703-A-G | Uncertain significance (May 20, 2022) | |||
1-64050706-C-T | Inborn genetic diseases | Uncertain significance (Jun 12, 2023) | ||
1-64137385-G-T | Inborn genetic diseases | Uncertain significance (Nov 15, 2021) | ||
1-64137412-A-G | Uncertain significance (Nov 11, 2021) | |||
1-64137431-T-C | Inborn genetic diseases | Uncertain significance (Sep 17, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ROR1 | protein_coding | protein_coding | ENST00000371079 | 9 | 407489 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.996 | 0.00355 | 125741 | 0 | 7 | 125748 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.17 | 373 | 511 | 0.730 | 0.0000286 | 6147 |
Missense in Polyphen | 137 | 225.59 | 0.60731 | 2612 | ||
Synonymous | 1.09 | 171 | 190 | 0.900 | 0.0000106 | 1867 |
Loss of Function | 4.79 | 4 | 34.3 | 0.117 | 0.00000165 | 437 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000352 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Has very low kinase activity in vitro and is unlikely to function as a tyrosine kinase in vivo (PubMed:25029443). Receptor for ligand WNT5A which activate downstream NFkB signaling pathway and may result in the inhibition of WNT3A-mediated signaling (PubMed:25029443, PubMed:27162350). In inner ear, crucial for spiral ganglion neurons to innervate auditory hair cells (PubMed:27162350). {ECO:0000269|PubMed:25029443, ECO:0000269|PubMed:27162350}.;
- Disease
- DISEASE: Deafness, autosomal recessive, 108 (DFNB108) [MIM:617654]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:27162350}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Nuclear Receptors;Wnt Signaling Pathway;Wnt Signaling Pathway;Signaling by WNT;Signal Transduction;WNT5A-dependent internalization of FZD2, FZD5 and ROR2;PCP/CE pathway;Beta-catenin independent WNT signaling;Wnt
(Consensus)
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- loftool
- 0.189
- rvis_EVS
- -1.59
- rvis_percentile_EVS
- 3.05
Haploinsufficiency Scores
- pHI
- 0.888
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.601
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.403
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ror1
- Phenotype
- craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; skeleton phenotype; embryo phenotype; respiratory system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- transmembrane receptor protein tyrosine kinase signaling pathway;sensory perception of sound;astrocyte development;peptidyl-tyrosine phosphorylation;positive regulation of I-kappaB kinase/NF-kappaB signaling;inner ear development;anatomical structure development;positive regulation of NF-kappaB transcription factor activity;Wnt signaling pathway, planar cell polarity pathway
- Cellular component
- stress fiber;plasma membrane;integral component of plasma membrane;cell surface;axon;receptor complex;axon terminus
- Molecular function
- transmembrane receptor protein tyrosine kinase activity;protein binding;ATP binding;Wnt-protein binding;Wnt-activated receptor activity;coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway